论文部分内容阅读
In our study, targeting Anti-EGFR mAb NDOA co-modified cationic liposomes loaded with Survivin-siRNA and MRP1-siRNA (EGFR-PEG-NCLs-siRNA) were formulated, with an appropriate particle size, zeta potential and high encapsulation efficiency.